Stock Events

Stock Events

Savezone I&C 

₩2,400
1
+₩0+0% 02:19 Today

Statistics

Day High
2,415
Day Low
2,380
52W High
4,135
52W Low
2,050
Volume
3,908
Avg. Volume
56,668
Mkt Cap
98.5B
P/E Ratio
-
Dividend Yield
1.25%
Dividend
30

Upcoming

Dividends

1.25%Dividend Yield
Apr 26
₩30
Apr 25
₩30
Apr 24
₩30
Apr 23
₩30
Apr 22
₩30
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

14NovExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-3.46
34.51
72.47
110.44
Expected EPS
N/A
Actual EPS
12.4318

Financials

9.79%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
174.5BRevenue
17.09BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Hlb co. ltd.
028300.KQ
Mkt Cap3.41T
Healthever is a competitor because it also operates in the health and wellness sector in South Korea, offering products that overlap with Savezone I&C's offerings.
Celltrion Health Care
091990.KQ
Mkt Cap11.33T
Celltrion Healthcare competes directly in the biopharmaceutical space, distributing products that can be in direct competition with Savezone I&C's healthcare products.
Celltrion Pharm
068760.KQ
Mkt Cap1.74T
Cell Biotech is involved in the development and manufacturing of probiotics, which competes with Savezone I&C's health supplement product lines.
Seegene
096530.KQ
Mkt Cap1.3T
SillaJen, Inc. focuses on biopharmaceutical products, particularly in the therapeutic areas where Savezone I&C is also trying to make an impact.
Access Bio
950130.KQ
Mkt Cap79.67B
Genexine is engaged in the clinical stage biotechnology sector, developing therapies that could compete with Savezone I&C's health-related products.
Kyongbo Pharmaceutical
214390.KQ
Mkt Cap0
Kyung Dong Pharmaceutical is a direct competitor in the pharmaceutical and health products market in South Korea.
Bcworldpharm
200780.KQ
Mkt Cap33.12B
Biocure Technology operates in the biopharmaceutical field, developing products that could rival Savezone I&C's offerings in the healthcare market.
Komipharm International.
041960.KQ
Mkt Cap552.04B
PeopleBio is known for its focus on neurodegenerative diseases, offering products that could compete with Savezone I&C's neurological health solutions.
Humasis.
205470.KQ
Mkt Cap51.48B
PharmAbcine develops and commercializes therapeutic antibodies, which are part of the broader biopharmaceutical market where Savezone I&C is also present.
e-Credible
092130.KQ
Mkt Cap174.51B
Nanobrick, while primarily a nanotechnology company, produces materials that are used in medical applications, indirectly competing with Savezone I&C's product lines.

About

Headquartered in Seoul, South Korea, Savezone I&C Corporation was founded in 2002 and primarily operates discount fashion retail outlets across the country. Beyond its retail ventures, the company also manages various public amenities, such as cultural and sports centers. The firm was formerly recognized as Uless Co., Ltd. before it rebranded to Savezone I&C Corporation in 2004.
Show more...
CEO
Myeong-Jin Kang
Employees
366
Country
South Korea
ISIN
KR7067830000

Listings

KQ
KR
067830.KQ

0 Comments

Share your thoughts

FAQ

What is Savezone I&C stock price today?▼
The current price of 067830.KQ is ₩2,400 KRW — it has increased by +0% in the past 24 hours. Watch Savezone I&C stock price performance more closely on the chart.
What is Savezone I&C stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Savezone I&C stocks are traded under the ticker 067830.KQ.
Is Savezone I&C stock price growing?▼
067830.KQ stock has fallen by -2.04% compared to the previous week, the month change is a +5.74% rise, over the last year Savezone I&C has showed a -10.63% decrease.
What is Savezone I&C market cap?▼
Today Savezone I&C has the market capitalization of 98.5B
What were Savezone I&C earnings last quarter?▼
067830.KQ earnings for the last quarter are 12.43 KRW per share, whereas the estimation was N/A KRW resulting in a N/A surprise. The estimated earnings for the next quarter are N/A KRW per share.
What is Savezone I&C revenue for the last year?▼
Savezone I&C revenue for the last year amounts to 174.5B KRW.
What is Savezone I&C net income for the last year?▼
067830.KQ net income for the last year is 17.09B KRW.
Does Savezone I&C pay dividends?▼
Yes, 067830.KQ dividends are paid annual. The last dividend per share was 30 KRW. As of today, Dividend Yield (FWD)% is 1.25%.
How many employees does Savezone I&C have?▼
As of September 08, 2026, the company has 366 employees.
In which sector is Savezone I&C located?▼
Savezone I&C operates in the Lifestyle & Brands sector.
When did Savezone I&C complete a stock split?▼
The last stock split for Savezone I&C was on April 03, 2006 with a ratio of 5:1.
Where is Savezone I&C headquartered?▼
Savezone I&C is headquartered in Seoul, South Korea.